Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`U.S. PATENTS
`
`Pages, Columns,
`Nameof Patentee or
`Issue or
`Document Number
`Exami was
`
`
`
`
`ner Publication Date|Applicant of Cited Document. _ Lines, Where
`Initials
`Number-Kind Code* (if
`YYYY-MM-DD
`Relevant Passages or
`
`known)
`
`Relevant
`Figures Appear
`
`
`[|reseassatessomesen—SOSC—C~idSCi‘;*S*SCSC~*”
`P|fesssrsfase
`
`[|Jaoser20—————asrr-os-on[rerasteran
`
`CreeeeVASILIEVICH etal
`
`[|fasionresniewiee
`[assistJaina
`
`[|Fasosoas_____[asas-0a-12_[MeyersetarSdSSCS
`
`[|farnasrs—____fasaraa-a2[kearnseta.SidSS
`
`[|arass00[kamarei_Sd—____[asee-06-07
`
`[|fastens[aseo-03-21[keamnseta,——S—*idCSSSSSSSCSCS*S
`
`[|Jso0628__fasei-oa-09[rubineta.SdSSSSSCSC—~S
`[|s2ees6a——————fasea.an-30[Modoer——SSSdYSSS
`[|Jsaaies_____[asos-o7-1e_[Larsson-enckstaom[SSCS
`
`
`
`[|Jentaass[earner——_faooi-oa-t0SSCS
`
`[|esasars___|a002-02-12[TranouchitatSdSSS
`[|esaze7—__]ao03-03-25fareronSidSSSSCSCSC~S
`
`[|Jse002ss_|ao0e-10-05[acaupowawarnw[SS
`[|Frasasos___[ao0s-02-10[orioetaSdSSCS
`
`
`[|Prsesaar_faor0-02-23[rockway—SSd|SS
`
`[|Jaosoaas___|a0is-10-04|sampatsFoti
`[|aaraasa____faorz-to-a2_|sampais__——S—SidSSS
`
`
`[|Jaaeae7s2013-02-26|sampais——SsdtSSS
`[|Jaseese7————=iaonssan-as_[sawpauseSdSSCS
`
`[|Jassrise__faora-oaas—[oruneimetas«(|SSS
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`U.S. PUBLISHED PATENT APPLICATIONS
`
`Pages, Columns,
`Nameof Patentee or
`Issue or
`Document Number
`Exami Cite
`No.
`
`
`
`
`ner ,¢|Publication Date|Applicant of Cited DocumentK 4 Lines, Where
`Initials
`Number-Kind Code"
`YYYY-MM-DD
`Relevant Passages or
`(if
`known)
`Relevant
`Figures Appear
`[|[onanareass—_—_—_—fr00r0620|sotySid—SCSSCSC~*”
`[|[oosooaaass[2003-03-06_|kacananderawn|——SS—iS
`[|Jeooaoniaase[2003-06-19[oshitom——S«dY|=SSSCSCSCSC~*™
`
`[|Jooanzaivas[2002-12-02_|sawraus+——S—=S
`[|[oosoo0so7s|2005-01-06|rwovaroveta
`
`[|Jovsoo7asas|2006-00-13[SusieRockway
`[|Jaovsoisass2|2006-08-31|karnyaeta,
`[|Jaoosonssais[2008-07-10[Sones
`[|Jaoosonssais[2008-07-10[Sones
`
`[|[ooeonssa20[2008-07-10_|scottFSones
`[|[ooeorsea7[2008-10-30_[Rubinetak
`
`
`
`[|Jporooraasri[2010-06-10[reivk———S—S«d—SSSSSCSCSC~SY
`
`
`
`[|Jaoio0rs0sss|2010-06-24|catennole———~+|———S~—~™
`[|[oioozass77[2010-09-09_[ruserwsnonreetas|———S—=S
`P|Joisors0ass[2011-06-02_[raraidrevik<i=SSSSSSC—C*™
`P|fousnisoxsi[2011-06-30_|sawraus,.|—————d
`[|Jaoisozas2as[2011-09-15[opheimeta.|——SSS—~d
`[|Jaoiaazzaaso[2010935|scaboseta,__——~+|SCS
`[—Jaoroas62x6[2011-10-20_|uerwowmrzanbrewe|_————d
`[—faoraoaraa6s[20100018_|encewerneta.|————+
`
`[—faoraoa7oias[2010-12-18|Hoew,wiseta.|__|
`Note: Submission of copies of U.S. Patents and published U.S. Patent Applications is not required.
`
`FOREIG-N PATENT DOCUMENTS
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`FOREIG-N PATENT DOCUMENTS
`
`
`
`
`Exami|Cite Publication Date Nameof Patentee or Pages, Translati
`
`ner | No." Foreign Patent Document}
`YYYY-MM-DD
`Applicant of Cited
`Columns,
`on®
`Initials
`Document
`Lines, Where
`Relevant
`Passagesor
`Relevant
`Figures
`Appear
`
`Country Code® Number®
`Kind Code’ (if known)
`
`AU 2002322233
`
`2003-02-17
`
`Neptune Technologies &
`Bioressources,Inc.
`SATO
`
`BR 8701265
`
`CA 1098900
`
`1987-03-12
`
`1981-04-07
`
`Inst.
`
`CA 1098900
`
`CA 2251265
`
`1981-04-07
`
`2000-04-21
`
`Elementoorganicheskikh
`So, et al.
`
`ROGOZHIN, et al
`
`Tepual S.A.
`UNIV. SHANDONG
`NORMAL
`
`
`
`CL 40348
`CN 102746941
`
`1997-07-08
`2014-01-15
`
`|| EP 0609078 1994-08-03 SCOTIA HOLDINGS PLC P
`
`EP 0973532
`
`2005-09-07
`
`1.B.R ISRAELI
`
`BIOTECHNOLOGY
`
`EP 1123368
`
`eee
`
`2008-04-09
`
`UNIVERSITE DE
`
`LTD
`
`
`
`EP 1385500
`
`2010-07-28
`
`YEDA RESEARCH ANDeRaz65500 DEVELOPMENTCO. LTD
`
`LEMeottoerconromanon||BOULDER CORPORATION
`|eetxomssounesme||
`P|rereeesomsourcesme||
`
`EP 1406641
`
`2004-04-14
`
`NEPTUNE TECHNOLOGIES
`
`EP 1419768
`
`2009-01-07
`
`NEPTUNE TECHNOLOGIES
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`FT EP 1542670
`EP 1631280
`
`FOREIG-N PATENT DOCUMENTS
`2005-06-22
`SUNTORYLIMITED
`2004-04-08
`BTG INTERNATIONAL
`
`LIMITED
`
`pf|EP1660071 NIPPONSUISANKAISHA, |||=| EP 1689413 2007-01-17
`
`
`ptEP1743531
`2007-01-17
`NIPPONSUISANKAISHA, a
`
`FT EP 1706106
`
`2006-08-16
`2009-07-15
`
`ENZYMOTEC LTD
`BRUZZESE
`
`
`
`[|[ee2oevo1a—————fieaaoa7_eanorr
`[Sanssareerecente
`[|woxoasos1___frov0-02a9_[sunrorvur>|—SSSidYSCCS
`
`
`[|roaoszass___|1990.02.25_[cwuonineenacorpu|__|
`JP 2003-530448
`2003-10-14
`Westfalia Separator
`Industry GmbH
`
`[fre200e-ssaa00__frooaiia_[kohyopecmceee{|
`
`ismasnome
`[|paseaaay____]1996-084_[TAYOFISHERYCOLTD|
`[|pas09s0s___|1998-06.23_[Tavorisuenvcour|___—_
`
`[[fraseaisa____|1990-02.25[CHLORINECORPLTD[|___—_ENG
`
`
`
`
`[|paoeiés2___|19a.07-19[CHLORINEcORPLTD|___—_ENG
`
`
`[||paaaaser___|1o97-0708[IKEDAsHOxxenek|——<dY——s
`[||eaasr7sa______|2008-09.05_[NiPPoNOLaFarscomm]__—+|——s
`[||racesrre[200-1031_[aneencnosscorp|+t——s
`
`[—[ieseniza2____}1s97-0805_[cHLonINeenGconPumD|—~|
`
`
`
`[|pacreaa72005-05-20_[cHLoRINeeNGcorptro|__|_
`JP 4012665
`1992-01-17
`MATSUSHITA ELECTRIC IND
`
`JP 60-153779
`
`1985-08-13
`
`JP 61281159
`
`1986-12-11
`
`JP HO8-231391
`
`CO LTD
`
`Honen Seiyu Co. Ltd. Et al.
`
`SHISEIDO CO LTD; NIPPON
`SUISAN KAISHA LTD.
`
`Kanagawa Kagaku
`Kenkyuujo Co., Ltd. Et al.
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`
`
`Nippon Suisan Kaisha, Ltd.
`Aker Biomarine ASA Po
`MAT-CON RADGIVENDE
`INGENIGRFIRMA A/S
`MIKALSEN Po
`1990-05-31
`FT WO 1990/05765
`a2Signature
`
`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`[JP $6323819
`JP-A-2001-158736
`
`FOREIG-N PATENT DOCUMENTS
`1988-02-01
`HARAKK.etal. Fo
`2001-06-12
`SNOW BRAND MILK PROD
`
`CO LTD
`UNITIKA LTD P
`2003-01-08
`FT JP-A-2003-003192
`
`|| JP-A-2003-048831 2003-02-21 SUNTORYLTD P
`
`JP-A-2003-146883
`2003-05-21
`SNOW BRAND MILK PROD
`CO LTD
`
`pt JP-A-2005-245379
`FT JP-A-2006-069948
`JP-A-2006-083136
`
`2005-09-15
`2006-03-16
`2006-03-30
`
`NIPPON SUISAN KAISHA
`LTD
`HIROSE YUKIHIRO
`SUNTORY LTD
`
`JP-A-2006-290784
`
`2006-10-26
`
`HIROSE YUKIHIRO
`
`JP-A-2006-316073
`
`2006-11-24
`
`IBR ISRAELI
`
`BIOTECHNOLOGY
`
`RESEARCH LTD
`
`JP-A-2006-328014
`
`2006-12-07
`
`HIROSE YUKIHIRO
`
`JP-A-2007-126455
`
`2007-05-24
`
`FUJI CHEM IND CO LTD
`
`JP-A-2007-246404
`
`2007-09-27
`
`SNOW BRAND MILK PROD
`
`a=
`
`CO LTD
`[—feassiaas77—_|19763-02|NiciroGyoeyoetal
`[fieasseanaoas~|1977-0924kaki
`[—|suzzoma——__——_—(figvioxos_[kRGUGKOV___——_—
`WO 01/76385
`2001-10-18
`Westfalia Separator
`Industry GmbH
`Neptune Technologies &
`Bioress
`
`WO 02/102394
`
`2002-12-27
`
`2008-10-02
`1986-10-23
`
`=====
`
`|| [wo 08/117062
`WO 1986/06082
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`Considered
`
`

`

`FT WO 2000/23546
`
`ptWO2000/25608
`
`FT WO 2000/38708
`WO 2001/028526
`
`2000-04-27
`
`2000-05-11
`
`2000-07-06
`2001-04-26
`
`
`
`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`|SheetPTAttorneyDocketNumber|AKBM-14409/US-18/CON
`
`FT WO 1993/24142
`WO 1997/38585
`
`FOREIG-N PATENT DOCUMENTS
`1993-12-09
`PHAIRSON MEDICAL AB
`1997-10-23
`THE UNIVERSITY OF
`BRITISH COLUMBIA
`
`BRIGHAM AND WOMEN’S
`HOSPITAL
`
`
`
`WO 1997/39759
`
`1997-10-30
`
`|| [wo 1998/34498 1998-08-13 BIOZYME SYSTEMSINC.
`
`UNIV SHERBROOKE
`
`NIPPONSUISANKAISHA, ——
`
`PHAIRSON MEDICALINC. Po
`TRUFFINI & REGGE
`FARMACEUTICI
`[—[_|wo200ivoeass—_[aooiii-os[HENDERSON
`
`[espeeeePp
`|emerPeer[eouoencomorsion||BOULDER CORPORATION
`pfhemi[eelessMS||
`|emerPeres[leonwenrcost
`P|emerPPPS[eSomssoureeswe
`& BIORESSOURCES INC.
`FT WO 2004/028529
`2004-04-08
`SUNTORYLIMITED
`[||wo200sroisas7[2008-02-20_[SunroRvureD
`
`DEVELOPMENTCO. LTD
`
`& BIORESS
`
`DEVELOPMENTCO. LTD
`
`FT WO 2004/047554
`WO 2004/112767
`
`2004-06-10
`2004-12-29
`
`WO 2004-100943
`
`2006-05-31
`
`-_—
`
`PHARES PHARM RES NV P
`AdvancedBionutrition
`Corp.
`BTG INTERNATIONAL
`
`LIMITED
`[|_|200sroaveas—_faoos-0x28_enzmorecim|
`
`
`[|_|wo20057038037[2005-04-28_[ENZ¥MOTECINC.___|
`[||wo200svo7oaix[2005-0804_aruzzese«|——SCidYCOC*
`P—[Jwo2005-01863[2005-03-08_areinreawanowa||_|
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`FOREIG-N PATENT DOCUMENTS
`CieCrCS
`[||wo200s7oa0552_fa006.0323_|sunrorvuwimed|—~dY——s
`aa
`
`[—[|wo2007/0805i5[2007-07-19[AKERBIOMARINEASA
`
`pf|WO2007/108702
`
`2007-09-27
`
`AKERSEAFOODSHOLDING—
`
`[|}wo20087005607[20080317__[NATTOPHARWARSA
`ee
`[|}wo20087007692[2009-03-05_[axersiowarweasa|__|___|
`[|}wo2010/0s7r0_[201009-02_[axensiomarmeasa|__|__|
`[|Jwo2012/0507[2011-05-05_[acasripuarwaw.||__|
`[|Jwo2012739588[2012018_[TmipuennepHanwans||__|
`[|Jwo2oisraczre2[2013-07-11_[oympicseafooaas|(|_|
`
`[|Jwo2niaorsaas[20140123[nownist.|+d+d
`[|Jwoszjozeis___asa2-00-02_[aticrsnua(|+d—*d
`[|fwossjoiosi[1989-02-09_[Pharmaciaas——~+|«dCs
`[|Jwosg/noseo[2989.11.16_[Pharmaciaas——~+|«id——*d
`WO 97/38585
`1997-10-23
`The University of British
`Columbia
`| wo 98/34498 Biozyme Systems, Inc.|=||1998-08-13
`
`Society of Scientific Fisheries, 1984, 50(5): 821-826
`
`
`
`
`
`Examin
`er
`Initials
`
`i
`
`.
`
`NONPATENT LITERATURE DOCUMENTS
`
`Include nameof the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, page(s), volume-issue number(s), publisher, city and-or country where
`published.
`Action Closing Prosecution, 348 Patent, mailed May 14, 2013
`
`ALI-NEHARI et al., "Characterization of purified phospholipids from krill () residues
`deoiled by supercritical carbon dioxide", Korean Journal of Chemical Engineering,
`2012, vol. 29, no. 7
`
`Translatio
`n°
`
`ALLAHPICHAYetal., “Extraction of Growth Promoting Fractions from Non-muscle Krill
`Meal of Euphausia superba and its Effect on Fish Growth," Bulletin of the Japanese
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`|SheetPtAttorneyDocketNumber|AKBM-14409/US-18/CON
`
`NONPATENT LITERATURE DOCUMENTS
`
`ANDOand HATANO,1988,“Isolation of apolipoproteins from carotenoid-carrying
`lipoprotein in the serum of chum salmon, Oncorhynchus keta”, J. Lipid Research, 29:
`1264-1271
`
`AOl et al., 2003, “Astaxanthin limits exercise-induced skeletal and cardiac muscle
`damage in mice”, Antioxidants & Redox Signaling, 5(1): 139-44
`
`——April2,2012ResponsetoOfficeAction,‘351patent
`
`|_| BALASSA et al., Microencapsulation in the Food Industry, Critical Reviews in Food| BALASSAet 2:2, 245-265 (1971)(“Balassa”)
`
`P|
`
`diseases”, Am. J. Clin. Nutr., 83: 1505S
`
`BELL and Dick, Molecular Species Composition of the Major Diacyl
`Glycerophospholipids from Muscle, Liver, Retina and Brain of Cod (Gadus morhua),
`Lipids, Vol. 26, No. 8, pp. 565-573 (1991) (“Bell and Dick”)
`BELL, Molecular Species Analysis of Phosphoglycerides from the Ripe Roes of Cod,
`Lipids, Vol. 24, No. 7 (1989)
`BELL, Molecular Species Composition of Phosphatidylcholine from Crypthecodinium
`cohnii in Relation to Growth Temperature Lipids 25, 115-118 (1990)
`
`BERGELSON(ed.), LipidBiochemicalPreparations, Chapter|.1, pp. 1-13 (1980) po
`
`(“Bergelson”)
`BOTTINO N.R., “Lipid Composition of Two Species of Antarctic Krill: Euphausia
`Superba and £. Crystallorophias,” Comp. Biochem. Physiol., 1975, Vol. 50B, pp.
`479-484
`
`BRITTON, 1985, “General Carotenoid Methods”, Methods in Enzymology, Vol 111, pp. po
`
`113-149
`
`BRZUSTOWICZ, Michael R., et al., “Controlling Membrane Cholesterol Content. A
`Role for Polyunsaturated (Docosahexaenoate) Phospholipids," Biochemistry (2002),
`Al, pp. 12509-12519
`FT Buchi R-220 Rotovapor® Manual, dated November16, 2009, pages 1-50 P|
`BUDA,Structural order of membranes and composition of phospholipids in fish brain
`cells during thermal acclimatization, Proc. Natl. Acad. Sci. USA Vol. 91, pp. 8234-8238,
`August 1994
`BUDZINSKLI, E., et al., “Possibilities of processing and marketing of products made
`from Antarctic Krill", FAO Fish. Tech. Pap. (268) 46 pages (1985) (BUDZINSKI)
`BUNEAR., et al.., "Evaluation of the Effects of Neptune Krill Oil on the Clinical Course
`of Hyperlipidemia," Alternative Medicine Review, Thorne Research Inc., Sandpoint,
`US, Vol. 9, No. 4, January 1, 2004
`CALDER, 2006, “n-3 polyunsaturated fatty acids, inflammation, and inflammatory
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`|SheetPT8AttorneyDocketNumber|AKBM-14409/US-18/CON
`
`NONPATENT LITERATURE DOCUMENTS
`
`Certificate of translation of Ex. 1072: Fisheries Agency, General Report on Research
`and Development of Techniques in Processing and Utilization of Marine Products,
`Chapter 6, Development of technology for recovery of valuable substances
`(astaxanthin) from krill, by Takao Fujita, pp. 273-307 (March 1985); Japanese
`language document
`
`Certificate of translation of Ex. 1074: Japanese Patent No. 60-153779, entitled
`“Nutritional Supplement”
`Certificate of translation of Ex. 1076: Japanese Patent Publication No. HO8-231391,
`entitled “Medicine for Improvement of Dementia Symptoms”
`Certification of translation of Ex. 1070: Japanese Unexamined Patent Application
`Publication No. 02-215351
`
`Certified translation of Ex. 1070: Japanese Unexamined Patent Application
`Publication No. 02-215351,titled Krill Phospholipids Fractioning Method
`(“Maruyama,”); Certificate of Translation provided as Ex. 1071; dated July 9, 2013, 1
`page
`
`Certified translation of Ex. 1072: Fisheries Agency, General Report on Research and
`Development of Techniques in Processing and Utilization of Marine Products,
`Chapter 6, Development of technology for recovery of valuable substances
`(astaxanthin) from krill, by Takao Fujita, pp. 273-307 (March 1985) (“Fujita”) ;
`Certificate of Translation provided as Ex. 1073.
`
`
`
`Certified translation of Ex. 1074: Japanese Patent No. 60-153779, entitled
`“Nutritional Supplement” (“Fukuoka ”); Certificate of Translation provided as Ex.
`1075, dated August 16, 2013
`Certified translation of Ex. 1076: Japanese Patent Publication No. HO8-231391,
`entitled “Medicine for Improvement of Dementia Symptoms”(“Yasawa”); Certificate
`of Translation provided as Ex. 1077, dated August 16, 2013, 1 page
`CHARESTetal., 2001, “Astaxanthin Extraction from Crawfish Shells by Supercritical
`CO2 with Ethanol as Cosolvent”, J. Aquatic Food Product Technology, 10(3): 79-93
`CHEN and MEYERS,1982, “Extraction of Astaxanthin Pigment from Crawfish Waste
`Using a Soy Oil Process”, J. Food Sci., 47: 892-896
`CLARKE, 1980, “The Biochemical Composition ofKrill, Euphausia superba dana,from
`South Georgia”, J. Exp. Mar. Biol. Ecol., 43: 221-236
`CN Office Action mailed April 27, 2012, JP Patent Application No. 200880112125.6
`(and English translation)
`
`P_[_|enc2013-2004,sathedpp6asre235SSC
`CZECZUGA, 1974, “Comparative Studies of Carotenoids in the Fauna of the Gullmar
`Fjord (Bohuslan, Sweden). II. Crustacea: Eupagurus bernhardus, Hyas coarctatus and
`Upogebia deltaura”, Marine Biology, 28: 95-98
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`NONPATENT LITERATURE DOCUMENTS
`
`Database FSTA [Online} International Food Information Service, Frankfurt-Main;
`SHIBATA N. "Effect of fishing season on lipid content and composition of Antarctic
`krill (translated)" Database accession no. FS-1985-04-r-0091, abstract only
`FT DATABASE WPI Week 200682, ThomsonScientific, London, GB, 2006
`DE RITTER and PURCELL, 1981, “Carotenoid Analytical Methods”, Carotenoids as
`Colorants and Vitamin A Precursors: Technological and Nutritional Applications, pp
`815-882
`
`P|
`
`
`
`December8, 2011 Office Action, KR Patent Application No. 10-2010-7006897and its
`English translation
`Declaration of Bjorn Ole Haugsgjerd in support of Inter Partes Review of U.S. Pat. No.
`8,278,351 (“Haugsgjerd”), dated September 30, 2013, 12 pages
`Declaration of Bjorn Ole Haugsgjerd submitted during inter partes reexamination of
`parent patent U.S. 8,030,348 (“Haugsgjerd ‘348 Decl.”)
`Declaration of Dr. Albert Lee in Support of Inter Partes Review of U.S. Pat. No.
`8,278,351 (“Lee”)
`Declaration of Dr. Albert Lee in Support of Inter Partes Review of U.S. Pat. No.
`8,383,675 (“Lee”)
`Declaration of Dr. Chong Lee submitted during inter partes reexamination of parent
`patent U.S. 8,030,348 (“Yeboah Reexam Decl.”)
`
`Declaration of Dr. Earl White submitted during prosecution of parent patent U.S.
`8,030,348 (“2011 White Decl.”)
`Declaration of Dr. Ivar Storr@ in support of Inter Partes Review of U.S. Pat. No.
`8,278,351 (“Storr@”)
`Declaration of Dr. Ivar Storr@ in support of Inter Partes Review of U.S. Pat. No.
`8,383,675 (“Storrd”)
`Declaration of Dr. Jacek Jaczynski from inter partes reexamination of the parent
`patent U.S. 8,030,348 (“Jaczynski Reexam. Decl.”)
`Declaration of Dr. Jaczynski submitted during prosecution of parent patent U.S.
`8,278,351 (Jaczynski ‘351 Decl.”)
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review of U.S. Pat. No.
`8,278,351 (“Moore”)
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review of U.S. Pat. No.
`8,383,675 (“Moore”)
`
`Declaration of Dr. Richard van Breemen in Support of Inter Partes Review of U.S. Pat.
`No. 8,278,351 (“Van Breemen”)
`Declaration of Dr. Richard van Breemen in Support of Inter Partes Review of U.S. Pat.
`No. 8,383,675 (“Van Breemen”)
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`NONPATENT LITERATURE DOCUMENTS
`
`Declaration of Dr. Shahidi submitted during inter partes reexamination of parent
`patent U.S. 8,030,348 (Shahidi Reexam. Decl.”)
`Declaration of Dr. Shahidi submitted during prosecution of parent patent U.S.
`8,278,351 (Shahidi ‘351 Decl.”)
`
`
`
`Declaration of Dr. Suzanne Budgein Support of Inter Partes Review of U.S. Pat. No.
`8,278,351 (“Budge”)
`Declaration of Dr. Suzanne Budgein Support of Inter Partes Review of U.S. Pat. No.
`8,383,675 (“Budge”)
`Declaration of Dr. Thomas Brenna in support of Inter Partes Review of U.S. Pat. No.
`8,278,351
`
`Declaration of Dr. Thomas Brenna in support of Inter Partes Review of U.S. Pat. No.
`8,383,675
`
`Declaration of Dr. Thomas Gundersen submitted during inter partes reexamination of
`parent patent U.S. 8,030,348 (“Gundersen Decl.”)
`Declaration of Dr. Tina Sampalis submitted during inter partes reexamination of
`parent patent U.S. 8,030,348 (Sampalis”)
`Declaration of Dr. Van Breemen submitted during Ex parte Reexamination of the ‘351
`patent (Van Breemen ‘351 Reexam. Decl.”
`Declaration of Dr. Van Breemen submitted during Inter partes Reexamination of the
`‘348 patent (Van Breemen ‘348 Reexam Decl.”
`Declaration of Dr. Yeboah submitted during inter partes reexamination of parent
`patent U.S. 8,030,348 (“Yeboah Reexam Decl.”)
`Declaration of Dr. Yeboah submitted during prosecution of parent patent U.S.
`8,278,351 (“Yeboah ‘351 Decl.”)
`DEUTCH, 1995, “Menstrual pain in Danish women correlated with low n-3
`polyunsaturated fatty acid intake”, Eur. J. Clin. Nutr., 49(7): 508-16
`DIEZ et al., 2003, “The role of the novel adipocyte-derived hormone adiponectin in
`human disease”, Eur. J. Endocrinol., 148(3): 293-300
`Eichberg, “Lecithin — It Manufacture and Usein the Fat and Oil Industry,” Oils and
`Soap 51-54, 1939 (“Eichberg”)
`ELLINGSEN etal., 1987, “Biochemistry of the autolytic processes in Antarctic krill post
`mortem. Autoproteolysis.” Biochem. J. 246, 295-305
`FT EMODI, 1978, “Carotenoids: Properties and Applications”, Food Technology, 32(5): 38 P|
`EP Opposition filed February 13, 2014 by Olympic Seafood AS, EP Patent Application
`No. EP08718910I6
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`NONPATENT LITERATURE DOCUMENTS
`
`EP Opposition filed May 8, 2015 by Olympic Seafood AS, EP Patent No. 2144618
`includes: ENGE, "Declaration" MACKENZIE, "Certificate of Analysis" - Callahan
`Innovation
`
`EUNG-HO LEE,etal., "Studies on the Processing of Krill Sauce," J. Korean Soc. Food
`Nutr. 13(1) 97-106 (1984)
`Evidence in Support of Opposition, Rimfrost AS, Australian Patent Application No.
`2013227998,filed September 22, 2016, 22 pages
`(14409/AU-7/DIV)
`Expert Witness Report of Dr. Theodore Welch submitted in relation to ITC
`Investigation No. 337-TA-877 (“Welch”)
`Farkas, Composition and Physical State of Phospholipids in Calanoid Copepods from
`India and Norway, LIPIDS, Vol. 23, No. 6 (1988)
`
`Marine Crustacea”, Department of Biochemistry, University of Liverpool, pp. 268-270
`
`ae FELIX-VALENZUELAetal.,2001,“SupercriticalCO2/EthanolExtractionofAstaxanthin
`
`from Blue Crab (Callinectes Sapidus) Shell Waste”, Journal of Food Process
`Engineering, 24: 101-112
`FT Final Prospectus dated May 11, 2001 (“Final Prospectus”)
`Fisheries Agency, General Report on Research and Development of Techniquesin
`Processing and Utilization of Marine Products, Chapter 6, Development of
`technology for recovery of valuable substances (astaxanthin) from krill, by Takao
`Fujita, pp. 273-307 (March 1985); Japanese language document
`
`Folch, et al., A Simple Method for the Isolation and Purification of Total Lipids from
`Animal Tissues. J. Biol. Chem., 226, 497-509 (1957)
`FOX and SCHEER, 1941, “Comparative Studies of the Pigments of Some Pacific Coast
`Echinoderms”, The Biological Bulletin, 441-455
`FRICKE,et al., 1-O-Alkylglycerolipids in Antarctic Krill (Euphausia Superba Dana),
`Comp. Biochem. Physiol. (1986) 85B(1): 131-134
`FRICKE,et al., Lipid, Sterol and Fatty Acid Composition of Antarctic Krill (Euphausia
`superba Dana), Lipids (1984) 19(11): 821-827.
`GEUSENS etal., 1994, “Long-term effect of omega-3 fatty acid supplementation in
`active rheumatoid arthritis. A 12-month, double-blind, controlled study”, Arthritis
`Rheum., 37(6): 824-9
`GIGLIOTTI et al., “Extraction and characterisation oflipids from Antarctic krill
`(Euphausia superba)", Food Chemistry, 2011, vol. 125, no. 3, pages 1028-1036
`GILCHRIST and GREEN, 1960, “The Pigments of Artemia”, Proceedings of the Royal
`Society, Series B Biological Sciences, Vol 152 No. 946, pp 118-136
`GOODWIN and SRISUKH, 1949, “Some Observations on Astaxanthin Distribution in
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`NONPATENT LITERATURE DOCUMENTS
`
`Pf Antarctic Krill, Euphausia superba," Chem. Nat. Cmpds. (1990) 26(2), pp. 143-147
`
`GORDEEV,K.Y., et al. "Fatty Acid Composition of the Main Phospholipids of the
`
`GORDEEV,K.Y., et al. "Fatty Acid Composition of the Main Phospholipids of the
`Antarctic Krill, Euphausia superba," Khim. Prirod. Soed. 2 (1990), pp. 181-187
`FT Grant of Request for Ex parte Reexamination of the ‘351 patent
`GRANTHAM (1977) Southern Ocean Fisheries Survey Programme, FAO Rome,
`GLO/SO/77/3: 1-61.
`
`PF
`
`Grit et al., Hydrolysis of phosphatidylcholine in aqueous liposome dispersions, Int. J.
`Pharmaceutics 50:1-6 (1989)
`GULYAEV and BUGROVA, 1976 “Removing fats from the protein paste “Okean”.
`Konservnaya | Ovoshchesushil’naya Promyshlennost, (4), 37-8
`
`a HARDARDOTITIR and KINSELLA, 1988, “Extraction of Lipid and Cholesterol from Fish po
`
`Astaxanthin & Krill Lecithin, pp. 1-16 (on or before December 28, 1994) (“Itano”)
`
`Muscle with Supercritical Fluids” Journal of Food Science, 53(6): 1656-1658
`Henderson etal., Lipid Composition of the Pineal Organ from Rainbow Trout
`(Oncorhynchus mykiss), Lipids, Vol. 29, No. 5, pp. 311-317 (1994) (“Henderson ”)
`Herman and Groves, The Influence of Free Fatty Acid Formation on the pH of
`Phospholipid-Stabilized Triglyceride Emulsions, Pharmaceutical Research 10(5):774-
`776 (1993)
`HVATTUM, Erlend,et al., "Effect of soybean oil and fish oil on individual molecular
`species of Atlantic salmon...", Journal of Chromatography B, 748 (2000) 137-149
`
`ae IGARASHI,Daisuke,etal.,"PositionalDistributionofDHAandEPAin
`Phosphatidylcholine and Phosphatidylethanolamine from Different Tissues of
`Squids," J. Oleo Sci. Vol. 50, No. 9 (2001)
`
`
`
`[|_inrernavionatAQUAFEED,2006,vol9—SSSOS—SCS
`
`
`f_|_ParosasaMeatattitenopenersome
`
`f_|__Peorozesgtevotanetenonanforreresnioromreane
`
`||reteerieorsooisemaleate0semeen|
`No. PCT/IB2014/002130, mailed February 3, 2015
`
`
`
`
`[|_linternationalSearchReportforPCT/182007/000088,dated:2007-0626«|
`International Search Report, International Patent Application No.
`PCT/IB2016/000208, mailed May 13, 2016,
`Itano Refrigerated Food Co., Ltd., Bio & High Technology Announcement and Natural
`
`2009-03-11
`
`2010-06-24
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`NONPATENT LITERATURE DOCUMENTS
`
`(2009) (“Le Grandois”)
`
`ITOH et al., 2007; “Increased adiponectin secretion by highly purified
`eicosapentaenoic acid in rodent models of obesity and human obese subjects”,
`Arteriosclerosis, Thrombosis, and Vascular Biology; 27(9): 1918-1925
`JOHNSON and LUCAS, Comparison of Alternative Solvents for Oils Extraction, JAOCS
`60(2):229-242 (1983)
`JOHNSON etal., 1978, “Simple Method for the Isolation of Astaxanthin from the
`Basidiomycetous Yeast Phaffia rhodozyma”, Applied and Environmental
`Microbiology, 35(6): 1155-1159
`JONG-HO LEE, "A Review: Antioxygenic and Peroxide-decomposing Activities of
`Antarctic Krill Lipids," J. Korean Soc. Food Mutr. 13(3) pp. 326-333 (1984)
`JP Office Action mailed February 23, 2012, JP Patent Application No. 2010-522444
`(and English translation)
`Kl WOONG CHO,et al., "Lipid and Fatty Acid Composition of the Antarctic Krill
`Euphausia superba," Ocean Research 21(2): 109-116 (1999)
`KOLAKOWSKA, 1989,“Krill lipids after frozen storage of about one year in relation to
`storage time before freezing”, Die Nahrung Food, 33(3): 241-244
`KOLAKOWSKI and GAJOWIECKI, "Optimization of autoproteolysis to obtain and edible
`product ‘precipitate’ from Antarctic krill," Seafood Science and Technology, pp. 331-
`336
`
`KRIS-ETHERTON etal., 2002, “Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and
`Cardiovascular Disease”, Circulation, 106:2747-2757
`
`KRISTENSEN et al., 1989, “Dietary supplementation with n-3 polyunsaturated fatty
`acids and human platelet function: a review with particular emphasis on implications
`for cardiovascular disease”, J. Intern. Med. Suppl. 731:141-50
`KUNESOVAetal., 2006, “The influence of n-3 polyunsaturated fatty acids and very
`low calorie diet during a short-term weight reducing regimen on weight loss and
`serum fatty acid composition in severely obese women”, Physiol Res.; 55(1):63-72
`KYUN-KU KIM, et al., "Effects of Cooking and Drying Methods on the Polar Lipds
`Composition of Shrimp," Korean J. Food Sci. Technol. Vol. 21, No. 1, pp. 25-30 (1989)
`LAIGHTet al., 1999, “F2-isoprostane evidence of oxidant stress in the insulin
`resistant, obese Zucker rat: effects of vitamin E”, Eur. J. Pharmacol. 377(1): 89-92
`LAMBERTSON and BRAEKKAN, 1971, “Method of Analysis of Astaxanthin and its
`Occurrence in some Marine Products,” J. Sci. Food. Agr., Vol 22(2): 99-101
`
`LE GRANDOIS etal., Investigation of Natural Phosphatidylholine Sources: Separation
`and Identification by Liquid Chromatography -Electrospray lonization-Tandem Mass
`Spectrometry (LC-ESI-MS2) of Molecular Species, J. Agric. Food Chem., 57, 6014-20
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`

`

`Complete if Known
`|ApplicationNumber|
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`pArtUnit|
`|ExaminerName|
`
`NONPATENT LITERATURE DOCUMENTS
`
`LIBBY et al., 2006, “Inflammation and Atherothrombosis: From Population Biology
`and BenchResearch to Clinical Practice”, J. Amer. Coll. Card., 48 (9, Suppl. A): A33-
`A46
`
`LIN et al., Effect of Dietary N-3 Fatty Acids Upon the PhospholipidMolecular Species
`of the Monkey Retina, Invest Ophthalmol Vis Sci. 1994;35:794-803
`LOPEZ et al., 2004, “Selective extraction of astaxanthin from crustaceans by use of
`supercritical carbon dioxide”, Talanta, 64: 726-731
`MANDEVILLE, 1991, “Isolation and Identification of Carotenoid Pigments, Lipids and
`Flavor Active Components from Raw Commercial Shrimp Waste”, Food
`Biotechnology, 5(2): 185-195
`MEDINA et al., C Nuclear Magnetic Resonance Monitoring of Free Fatty Acid Release
`After Fish Thermal Processing, J. Amer. Oil Chem. Soc. 71(5):479-82 (1994)
`MEYERSand BLIGH, 1981, “Characterization of Astaxanthin Pigments from Heat-
`Processed Crawfish Waste”, J. Agric. Food Chem., 29: 505-508
`MEYERS, 1977, “Using Crustacean Meals and Carotenoid-Fortified Diets”, Feedstuffs,
`Vol. 49(19)
`MEYERS, 1994, “Developments in world aquaculture, feed formulations, and role of
`carotenoids”, Pure & Appl. Chem, Vol. 66(5): 1069-1076
`
`MILLS et al., 1989, “Dietary N-6 and N-3 fatty acids and salt-induced hypertension in
`the borderline hypertensive rat”, Lipids, 24(1): 17-24
`MOATESand VAN BENTEM, 1990,“Separating out the value”, Food Science and
`Technology Today, 4(4): 213-214
`Neptune krill Oil's Unique Properties", INTERNET CITATION, 2011,
`URL:http://www.nowfoods.com/Products/ProductFAQs/0